Encorafenib (Braftovi)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Encorafenib (Braftovi), covering 2025-11-18 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma [Phase 3]